Details for High Impact Journal

Superfund Research Program

Gastroenterology (impact factor: 19.233)

2019

• Castera L, Friedrich-Rust M, Loomba R. 2019. Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease. Gastroenterology 156(5):1264-1281. doi:10.1053/j.gastro.2018.12.036
• Liang S, Ma H, Zhong Z, Dhar D, Liu X, Xu J, Koyama Y, Nishio T, Karin D, Karin G, Mccubbin R, Zhang C, Hu R, Yang G, Chen L, Ganguly S, Lan T, Karin M, Kisseleva T, Brenner DA. 2019. NADPH Oxidase 1 in Liver Macrophages Promotes Inflammation and Tumor Development in Mice. Gastroenterology 156(4):1156-1172. doi:10.1053/j.gastro.2018.11.019 PMID:30445007 PMCID:PMC6409207

2018

• Ajmera V, Park CC, Caussy C, Singh S, Hernandez C, Bettencourt R, Hooker J, Sy E, Behling C, Xu R, Middleton MS, Valasek MA, Faulkner C, Rizo E, Richards L, Sirlin CB, Loomba R. 2018. Magnetic Resonance Imaging Proton Density Fat Fraction Associates with Progression of Fibrosis in Patients with Nonalcoholic Fatty Liver Disease. Gastroenterology 155(2):307-310. doi:10.1053/j.gastro.2018.04.014 PMID:29660324 PMCID:PMC6090543

2017

• Park CC, Nguyen P, Hernandez C, Bettencourt R, Ramirez K, Fortney L, Hooker J, Sy E, Savides MT, Valasek MA, Rizo E, Brenner DA, Sirlin CB, Loomba R. 2017. Magnetic resonance elastography vs transient elastography in detection of fibrosis and noninvasive measurement of steatosis in patients with biopsy-proven nonalcoholic fatty liver disease. Gastroenterology 152(3):598-607.e2. doi:10.1053/j.gastro.2016.10.026 PMID:27911262 PMCID:PMC5285304

2016

• Matsushita H, Yang YM, Pandol SJ, Seki E. 2016. Exosome migration inhibitory factor as a marker and therapeutic target for pancreatic cancer. Gastroenterology 150(4):1033-1035. doi:10.1053/j.gastro.2016.02.051 PMID:26922869 PMCID:PMC4905572

2015

• Roh Y, Loomba R, Seki E. 2015. The TM6SF2 variants, novel genetic predictors for nonalcoholic steatohepatitis. Gastroenterology 148(1):252-254. doi:10.1053/j.gastro.2014.11.014 PMID:25451657 PMCID:PMC4718074
• Yang YM, Roh YS, Seki E. 2015. MafG, a novel target of FXR that regulates bile acid homeostasis. Gastroenterology 149(7):1981-1983. doi:10.1053/j.gastro.2015.10.014 PMID:26501563 PMCID:PMC4744927

2014

• Schnabl B, Brenner DA. 2014. Interactions between the intestinal microbiome and liver diseases. Gastroenterology 146(6):1513-1524. doi:10.1053/j.gastro.2014.01.020 PMID:24440671 PMCID:PMC3996054

2013

• Yang L, Inokuchi-Shimizu S, Roh Y, Song J, Loomba R, Park E, Seki E. 2013. Transforming growth factor-beta signaling in hepatocytes promotes hepatic fibrosis and carcinogenesis in mice with hepatocyte-specific deletion of TAK1. Gastroenterology 144(5):1042-1054. doi:10.1053/j.gastro.2013.01.056 PMID:23391818 PMCID:PMC3752402

2012

• Fujiwara R, Chen S, Karin M, Tukey RH. 2012. Reduced expression of UGT1A1 in intestines of humanized UGT1 mice via inactivation of NF-kappa B leads to hyperbilirubinemia. Gastroenterology 142:109-U259. doi:10.1053/j.gastro.2011.09.045 PMID:21983082 PMCID:PMC3428231
• Seki E, Brenner DA, Karin M. 2012. A liver full of JNK: signaling in regulation of cell function and disease pathogenesis, and clinical approaches. Gastroenterology 143(2):307-320. doi:10.1053/j.gastro.2012.06.004 PMID:22705006 PMCID:PMC3523093

1998

• Campbell-Thompson M, Reyher KK, Lauwers GY, Shiverick KT. 1998. Estrogens modulate gastro-duodenal hyerplasia and dysplasia induced by N-methyl-N'-nitrosoguanidine in rats. Gastroenterology 114(4):G2347.